Web Stats Provided By Google Analytics

Friday, September 30, 2016

Regeneron Announces Phase 2 Study of Aflibercept Co-Formulated with...

... Pharmaceuticals, Inc. Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical ...
http://ift.tt/2cGXfOs

No comments:

Post a Comment

Popular Tarrytown Roundup Posts